GlassScriptPhysician profile
Tyler Cox
NPI 1518417955
$3,564.47
in general payments reported to CMS, 2019-2025
21 companies · $517 in 2025
The $517 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $735 · 2022: $660 · 2023: $1,061 · 2024: $591 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,169.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,164.56 | 2021-2025 | Dovato, Cabenuva, Apretude |
| Gilead Sciences, INC. | $782.68 | 2021-2025 | |
| Lilly USA, LLC | $438.98 | 2021-2025 | Mounjaro, Zepbound |
| Merck Sharp & Dohme LLC | $373.65 | 2021-2024 | Pifeltro, Delstrigo, Dificid |
| Novo Nordisk INC | $161.99 | 2021-2024 | Ozempic, Rybelsus |
| Janssen Products, LP | $99.95 | 2021 | |
| Abbvie INC. | $88.69 | 2023-2024 | |
| Glaxosmithkline, LLC. | $79.93 | 2022-2023 | Pediarix, Rotarix, Bexsero |
| Bayer Healthcare Pharmaceuticals INC. | $73.72 | 2022-2023 | |
| Pfizer INC. | $47.66 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $40.07 | 2022 | |
| Janssen Pharmaceuticals, INC | $39.29 | 2021-2022 | |
| Verona Pharma, INC. | $31.23 | 2025 | Ohtuvayre |
| Cipher Pharmaceuticals US LLC | $25.15 | 2025 | Spinosad, Natroba |
| Amgen INC. | $21.94 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $21.26 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $19.00 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.22 | 2022 | |
| Phadia US INC. | $13.65 | 2023 | Immunocap |
| Hologic INC | $12.99 | 2021 | |
| Mylan Pharmaceuticals INC. | $11.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.